Xiaowei Dong, Ph.D.
Affiliations: | 2009 | University of Kentucky, Lexington, KY |
Area:
Pharmaceutical Chemistry, Medicine and Surgery, OncologyGoogle:
"Xiaowei Dong"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Russell J. Mumper | grad student | 2009 | University of Kentucky | |
| (Lipid-based paclitaxel and doxorubicin nanoparticles to overcome P-gp-mediated drug resistance in solid tumors.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tanaudommongkon I, Tanaudommongkon A, Prathipati P, et al. (2020) Curcumin Nanoparticles and Their Cytotoxicity in Docetaxel-Resistant Castration-Resistant Prostate Cancer Cells. Biomedicines. 8 |
| Zhu J, Dong X. (2017) Preparation and Characterization of Novel HDL-mimicking Nanoparticles for Nerve Growth Factor Encapsulation. Journal of Visualized Experiments : Jove |
| Tanaudommongkon A, Tanaudommongkon I, Prathipati P, et al. (2017) Development and Characterization of Docetaxel-Loaded Nanoparticles for Docetaxel-Resistant Castration-Resistant Prostate Cancer Journal of Nanoscience and Nanotechnology. 17: 3920-3926 |
| Prathipati P, Zhu J, Dong X. (2016) Development of novel HDL-mimicking α-tocopherol-coated nanoparticles to encapsulate nerve growth factor and evaluation of biodistribution. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V |
| Guo S, Pham K, Li D, et al. (2016) Novel in situ self-assembly nanoparticles for formulating a poorly water-soluble drug in oral solid granules, improving stability, palatability, and bioavailability. International Journal of Nanomedicine. 11: 1451-60 |
| Pham K, Li D, Guo S, et al. (2016) Development and in vivo evaluation of child-friendly lopinavir/ritonavir pediatric granules utilizing novel in situ self-assembly nanoparticles. Journal of Controlled Release : Official Journal of the Controlled Release Society |
| Dong X, Mumper RJ. (2010) Nanomedicinal strategies to treat multidrug-resistant tumors: current progress. Nanomedicine (London, England). 5: 597-615 |
| Ma P, Dong X, Swadley CL, et al. (2009) Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia. Journal of Biomedical Nanotechnology. 5: 151-61 |
| Dong X, Mattingly CA, Tseng MT, et al. (2009) Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP. Cancer Research. 69: 3918-26 |
| Dong X, Mattingly CA, Tseng M, et al. (2009) Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization European Journal of Pharmaceutics and Biopharmaceutics. 72: 9-17 |